The Commission on Human Medicines (CHM) has endorsed changes to isotretinoin prescribing guidance. In addition, CHM is seeking further information from dermatology services who prescribe isotretinoin to inform any future cha…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.